199 related articles for article (PubMed ID: 31276705)
21. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization.
Sbrana F; Malacarne P; Bassetti M; Tascini C; Vegnuti L; Della Siega P; Ripoli A; Ansaldi F; Menichetti F
Minerva Anestesiol; 2016 Jun; 82(6):635-40. PubMed ID: 26745619
[TBL] [Abstract][Full Text] [Related]
23. A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates.
Spyropoulou A; Papadimitriou-Olivgeris M; Bartzavali C; Vamvakopoulou S; Marangos M; Spiliopoulou I; Anastassiou ED; Christofidou M
J Med Microbiol; 2016 Mar; 65(3):240-246. PubMed ID: 26698320
[TBL] [Abstract][Full Text] [Related]
24. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae.
Pournaras S; Kristo I; Vrioni G; Ikonomidis A; Poulou A; Petropoulou D; Tsakris A
J Clin Microbiol; 2010 Jul; 48(7):2601-4. PubMed ID: 20504985
[TBL] [Abstract][Full Text] [Related]
26. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
[TBL] [Abstract][Full Text] [Related]
27. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.
Papadimitriou-Olivgeris M; Fligou F; Bartzavali C; Zotou A; Spyropoulou A; Koutsileou K; Vamvakopoulou S; Sioulas N; Karamouzos V; Anastassiou ED; Spiliopoulou I; Christofidou M; Marangos M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1125-1131. PubMed ID: 28102514
[TBL] [Abstract][Full Text] [Related]
28. Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy.
Boattini M; Bianco G; Charrier L; Comini S; Iannaccone M; Almeida A; Cavallo R; De Rosa FG; Costa C
Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):431-439. PubMed ID: 36806056
[TBL] [Abstract][Full Text] [Related]
29. Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.
Cojutti P; Sartor A; Righi E; Scarparo C; Bassetti M; Pea F
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760900
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae.
Tumbarello M; Trecarichi EM; Corona A; De Rosa FG; Bassetti M; Mussini C; Menichetti F; Viscoli C; Campoli C; Venditti M; De Gasperi A; Mularoni A; Tascini C; Parruti G; Pallotto C; Sica S; Concia E; Cultrera R; De Pascale G; Capone A; Antinori S; Corcione S; Righi E; Losito AR; Digaetano M; Amadori F; Giacobbe DR; Ceccarelli G; Mazza E; Raffaelli F; Spanu T; Cauda R; Viale P
Clin Infect Dis; 2019 Jan; 68(3):355-364. PubMed ID: 29893802
[TBL] [Abstract][Full Text] [Related]
32. Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study.
Cano Á; Gutiérrez-Gutiérrez B; Machuca I; Torre-Giménez J; Frutos-Adame A; García-Gutiérrez M; Gallo-Marín M; Gracia-Ahufinger I; Artacho MJ; Natera AM; Pérez-Nadales E; Castón JJ; Mameli S; Gómez-Delgado F; de la Fuente C; Salcedo I; Rodríguez-Baño J; Martínez-Martínez L; Torre-Cisneros J
J Glob Antimicrob Resist; 2022 Jun; 29():476-482. PubMed ID: 34788693
[TBL] [Abstract][Full Text] [Related]
33. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
De Rosa FG; Corcione S; Cavallo R; Di Perri G; Bassetti M
Future Microbiol; 2015; 10(2):283-94. PubMed ID: 25689539
[TBL] [Abstract][Full Text] [Related]
34. Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients.
Cano Á; Gutiérrez-Gutiérrez B; Machuca I; Torre-Giménez J; Gracia-Ahufinger I; Natera AM; Pérez-Nadales E; Castón JJ; Rodríguez-Baño J; Martínez-Martínez L; Torre-Cisneros J
Microbiol Spectr; 2022 Apr; 10(2):e0197021. PubMed ID: 35323035
[TBL] [Abstract][Full Text] [Related]
35. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
36. Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort.
Castón JJ; Gallo M; García M; Cano A; Escribano A; Machuca I; Gracia-Aufinger I; Guzman-Puche J; Pérez-Nadales E; Recio M; Muñoz M; Martínez-Martínez L; Torre-Cisneros J;
Int J Antimicrob Agents; 2020 Sep; 56(3):106075. PubMed ID: 32629116
[TBL] [Abstract][Full Text] [Related]
37. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany.
Wendt C; Schütt S; Dalpke AH; Konrad M; Mieth M; Trierweiler-Hauke B; Weigand MA; Zimmermann S; Biehler K; Jonas D
Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):563-70. PubMed ID: 20213255
[TBL] [Abstract][Full Text] [Related]
38. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
39. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.
Lübbert C; Lippmann N; Busch T; Kaisers UX; Ducomble T; Eckmanns T; Rodloff AC
Am J Infect Control; 2014 Apr; 42(4):376-80. PubMed ID: 24679563
[TBL] [Abstract][Full Text] [Related]
40. A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.
Jousset AB; Bonnin RA; Rosinski-Chupin I; Girlich D; Cuzon G; Cabanel N; Frech H; Farfour E; Dortet L; Glaser P; Naas T
Clin Infect Dis; 2018 Oct; 67(9):1388-1394. PubMed ID: 29688339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
